Global cost modeling analysis of HIV-1 and HCV viral load assays

Tarek Elbeik, Ralph Dalessandro, Yi Ming Arthur Chen, Serguei V. Soutchkov, Richard A. Loftus, Scott Beringer

研究成果: 雜誌貢獻回顧型文獻同行評審

11 引文 斯高帕斯(Scopus)


This review addresses hidden costs associated with the Bayer VERSANT® assay, Roche AMPLICOR MONITOR® test and COBAS AMPLICOR MONITOR® test and how these influence the final per reportable cost to a testing laboratory in resource-rich and -poor countries. An in-depth evaluation and recommendation of the most cost-effective approach for these tests is presented. The analyses demonstrate the need for manufacturers to consider labor and supply costs when marketing a kit in resource-poor countries, noting that marketing strategies need to change. In the absence of any proven monitoring alternative, emphasis is placed on increasing market share to promote significant reduction in kit prices to suit the demands of markets in resource-poor countries. Finally, recommendations are made to improve the overall cost structure of viral load testing. This review is intended as a tool to optimize assay usage in attaining the lowest performance costs by assay and is not to endorse any test, as will become apparent.
頁(從 - 到)383-407
期刊Expert Review of Pharmacoeconomics and Outcomes Research
出版狀態已發佈 - 8月 1 2003

ASJC Scopus subject areas

  • 健康政策
  • 藥學(醫學)


深入研究「Global cost modeling analysis of HIV-1 and HCV viral load assays」主題。共同形成了獨特的指紋。